Ready for rapid rule-out of acute myocardial infarction

Goaris W A Aarts; Cyril Camaro; Niels van Royen

doi:10.1093/eurheartj/ehad519

Ready for rapid rule-out of acute myocardial infarction

Eur Heart J. 2023 Oct 12;44(38):3889-3891. doi: 10.1093/eurheartj/ehad519.

Authors

Goaris W A Aarts¹, Cyril Camaro¹, Niels van Royen¹

Affiliation

¹ Department of Cardiology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525GA, The Netherlands.

Abstract

Graphical Abstract

Pros and cons of a dual biomarker strategy for patients with a suspected acute myocardial infarction (AMI). Suspected AMI patients are transported to the emergency department (ED) to rule-in or rule-out an AMI. Chest pain is the most common reason for emergency medical contact and ED overcrowding is a growing problem worldwide. To reduce ED overcrowding, the efficiency of the diagnostic pathway of chest pain needs to improve. The AROMI study proposes an accelerated dual biomarker strategy to reduce the length of stay in the ED, which could reduce ED overcrowding. Pre-hospital strategies for rule-out of AMI could also improve the efficiency of the diagnostic pathway of chest pain. Together with pre-hospital strategies, the AROMI study further opens the door to rapid rule-out of AMI.

Publication types

Comment